Press Release|Articles|April 29, 2025
Camber Pharmaceuticals Launches Chlorzoxazone Tablets, USP
Listen
0:00 / 0:00
Key Takeaways
- Chlorzoxazone Tablets, USP, target relief from acute, painful musculoskeletal conditions as an adjunct therapy.
- The tablets are intended to complement rest, physical therapy, and other treatment measures.
Advertisement
Camber Pharmaceuticals is excited to announce the addition of Chlorzoxazone Tablets, USP.
Chlorzoxazone Tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.
Chlorzoxazone 250 mg Tablets, USP are available in 60 count bottles.
To find out more information on Chlorzoxazone Tablets, USP, please visit:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Daratumumab and Hyaluronidase-fihj With Quadruplet Regimen for Newly Diagnosed Multiple Myeloma
2
Study Finds No Evidence That Hormone Therapy Use Affects Dementia Risk in Postmenopausal Women
3
New AHA Scientific Statement Notes Socioeconomic, Structural Barriers to Addressing Obesity
4
Q&A: Medication Challenges and the Pharmacist’s Role in Multiple Sclerosis Care
5